Citigroup’s Rallybio RLYB Stock Holding History
Bought
Maintained
Sold
Other funds holding RLYB
CAM
TGA
LCM
NCM
PBPIA
5VM
AC
Citigroup's RLYB Position: Q1 2026 in Review
Citigroup sold out of Rallybio (RLYB) in Q1 2026, closing a stake of 492 shares — an estimated $2.7K sold.
Citigroup first reported a position in RLYB in Q3 2021 and held it in 15 quarters. The position peaked at $51.7K in Q2 2023. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.
- Citigroup reported no remaining Rallybio position as of Q1 2026 after selling out during the quarter.
- Citigroup sold 492 Rallybio shares in Q1 2026, an estimated $2.7K.
- Citigroup first reported a position in Rallybio in Q3 2021 and held it in 15 quarters.
- Citigroup's Rallybio position peaked at $51.7K in Q2 2023.
- 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.